MSD (Germany)

Recent papers from MSD (Germany)

1. ESMO and ASCO Consensus on Good Clinical Practice Guideline E6(R3): A Step Forward Towards Streamlining Clinical ResearchESMO Open · 2026
2. The impact of a nurse navigation program on health, economic and medical outcomes of cancer patients in Saxony – a multicenter, prospective, randomized controlled trialResearch in Health Services & Regions · 2026
3. In Patients Experiencing Pain and Inflammation, the Use of Non-Steroidal Anti-Inflammatory Drugs Is More Likely a Marker of the Observed Cardiovascular Risk Rather than Its Cause: A ViewpointPharmacy · 2026
4. Cost-effectiveness analysis of pneumococcal conjugate vaccines, PCV21 vs PCV20, in adults aged ≥60 years in GermanyExpert Review of Vaccines · 2026
5. Projected epidemiological impact of lowering the adult pneumococcal vaccination age from 60 to 50 years in GermanyHuman Vaccines & Immunotherapeutics · 2026
6. Time to subsequent therapy (TTST) as an endpoint in clinical studies: development of standardized documentation of subsequent therapy through systematic literature review, expert interviews, and Delphi surveyJournal of Cancer Research and Clinical Oncology · 2026
7. EXPRESS: Evaluation of the clinical course of immune-mediated polyneuropathy in cats following treatment with human intravenous immunoglobulinsJournal of Feline Medicine and Surgery · 2026
8. Targeted Micronutrient Supplementation in Diabetic Retinopathy With MTHFR Polymorphisms: Biomarker Shifts and Clinical UncertaintyCell Biochemistry and Function · 2026
9. Soluble Guanylate Cyclase Modulators in Glaucoma and Ocular Fibrosis: Mechanisms, Translational Evidence, and Therapeutic ChallengesJournal of Ocular Pharmacology and Therapeutics · 2026
10. Mapping the treatment journey following antibody-drug conjugate (ADC) initiation: Sequencing patterns and real world overall survival (rwOS) in non-breast solid tumors in a US community setting.Journal of Clinical Oncology · 2026
11. Real-world (rw) study of the treatment journey following antibody-drug conjugate (ADC) initiation and overall survival (OS) in breast cancer (BC) in a US community setting.Journal of Clinical Oncology · 2026
12. Prognosis and aetiology of hospital-acquired pneumonia (HAP) and ventilator-associated pneumonia (VAP) in patients with active lung or lower head and neck cancer (PEPP-C): a retrospective, matched multicentre cohort study in Germany and SpainInfection · 2026
13. Characterization of People Receiving 2-Drug Regimens (2DR) for HIV Management in ItalyInternational Journal of Sexually Transmitted Diseases · 2026
14. 377P Risk prediction for non-small cell lung cancer using longitudinal EMR data: A machine learning model in a national Israeli cohortESMO Open · 2026
15. Radiographic Appearance of the Urinary Bladder and Application of a Vertebral Bladder Score for Evaluating Bladder Size in Healthy Guinea Pigs (Cavia porcellus) and Guinea Pigs with Clinical Signs of CystitisAnimals · 2026
16. Immunopathogenesis of lung lesions induced by the highly virulent Rosalía strain of PRRSV-1 circulating in Spain since 2020The Veterinary Journal · 2026
17. Is there a link between non-steroidal anti-inflammatory drugs and cardiovascular risk in patients with inflammatory arthritis?Atherosclerosis Plus · 2026
18. Impact of early-stage immunotherapy on health and work productivity in the Czech Republic, 2024-2033.2026
19. Abstract GS2-01: More versus less invasive axillary surgical staging procedures in breast cancer patients converting from a clinically node-positive to a clinically node-negative stage through neoadjuvant chemotherapy - primary endpoint analysis of the international prospective multicenter AXSANA/EUBREAST 3(R)studyClinical Cancer Research · 2026
20. Cystitis in guinea pigs ( Cavia porcellus ): Clinical findings and treatment outcomesVeterinary Record · 2026